iShares Biotechnology ETF - IBB Stock Forecast, Price & News

iShares Biotechnology ETF's stock was trading at $152.62 at the beginning of the year. Since then, IBB stock has decreased by 10.1% and is now trading at $137.16.
View the best growth stocks for 2022 here.

iShares Biotechnology ETF saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 10,410,000 shares, an increase of 6.9% from the October 31st total of 9,740,000 shares. Based on an average trading volume of 1,962,100 shares, the days-to-cover ratio is presently 5.3 days.
View iShares Biotechnology ETF's Short Interest.

iShares Biotechnology ETF declared a quarterly dividend on Wednesday, June 8th. Shareholders of record on Friday, June 10th will be paid a dividend of $0.031 per share on Wednesday, June 15th. This represents a $0.12 annualized dividend and a dividend yield of 0.09%. The ex-dividend date of this dividend is Thursday, June 9th.
Read our dividend analysis for IBB.

iShares Biotechnology ETF (NASDAQ:IBB) pays an annual dividend of $0.35 per share and currently has a dividend yield of 0.25%.
Read our dividend analysis for IBB.

iShares Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Royal Bank of Canada (2.74%), Farallon Capital Management LLC (0.00%), Elliott Investment Management L.P. (0.00%), Jane Street Group LLC (1.45%), Commerce Bank (1.11%) and Citadel Advisors LLC (0.00%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IBB stock can currently be purchased for approximately $137.16.

iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $8.53 billion.